Study of In Utero Rx of Genetic Skin Disorder Underway

EDA loss or dysfunction precludes binding to its endogenous EDA1 receptor, and downstream development of teeth, hair, nails, and skin adnexae, most notably eccrine glands.
MDedge News

source https://www.medscape.com/s/viewarticle/995124?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost